Related Experiment Video
Updated: Aug 2, 2025

An in vivo Assay to Test Blood Vessel Permeability
Published on: March 16, 2013
Effect of coronaviruses on blood vessel permeability: potential therapeutic targets
Nicolle R Machado1, Karina T Dias1, Bryan F S Cortes1
1Laboratory of Vascular Nanopharmacology, Department of Pharmacology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, Brazil.
Insights
Coronaviruses cause severe illness, including COVID-19, by increasing vascular permeability in the lungs. This review covers updated aspects of coronavirus diseases and highlights lung vascular permeability as a drug target.
Area of Science:
- Virology
- Pathology
- Pharmacology
Background:
- Coronaviruses have caused significant global health issues for decades.
- The emergence of COVID-19 has led to a devastating global pandemic.
- Enhanced vascular permeability, particularly in the lungs, is a key feature of severe coronavirus infections.
Purpose of the Study:
- To review updated information on coronavirus-induced diseases.
- To focus on the role of enhanced vascular permeability in lung pathology.
- To identify vascular permeability as a therapeutic target for coronavirus infections.
Main Methods:
- Literature review of recent studies on coronaviruses and vascular permeability.
- Analysis of pathological mechanisms underlying lung injury in coronavirus disease.
- Synthesis of information on existing and novel drug targets related to vascular permeability.
Main Results:
- Coronaviruses significantly impact human health, with COVID-19 being a major global threat.
- Dysregulated vascular permeability in the lungs is a critical factor in coronavirus morbidity and mortality.
- Targeting vascular permeability offers a potential therapeutic strategy for managing severe coronavirus infections.
Conclusions:
- Understanding coronavirus pathogenesis, especially lung vascular permeability, is crucial.
- Therapeutic strategies aimed at modulating vascular permeability show promise for treating coronavirus diseases.
- Further research into drugs targeting vascular permeability could mitigate the impact of future coronavirus outbreaks.
Abstract:
Coronavirus-induced diseases have afflicted humanity for several decades. This scenario was aggravated by the emergence of the coronavirus disease 2019 (named COVID-19) in Wuhan, China, in December 2019. Since then, COVID-19 has killed millions of people worldwide, probably the most devastating pandemic since HIV/AIDS. This review aimed to bring together important updated aspects related to coronavirus-induced diseases and the enhanced vascular permeability observed mainly in the lungs of affected people. The dysregulated vascular permeability in the lungs is of fundamental importance for coronaviruses-caused morbidity and mortality. Thus, as described in this review, it is a target of new and old drugs.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Vascular Spasm

